Guangdong Jiaying Pharmaceutical announced that the company plans to use its own funds to repurchase part of its issued ordinary shares in Renminbi (A shares) through centralized bidding, for the purpose of implementing an employee stock ownership plan or Stock-based Incentive. The repurchase price will not exceed 9.80 yuan per share (inclusive), with the number of shares to be repurchased not less than 7 million shares (inclusive), accounting for about 1.3793% of the company’s total share capital; and not more than 13.5 million shares (inclusive), accounting for about 2.6600% of the company’s total share capital. The repurchase period is within 12 months from the date the Board of Directors approves the repurchase plan. The source of funding for the buyback will be the company's own funds.